This study validates the pharmacodynamic analgesic predictions (effect) given by Minto's remifentanil pharmacokinetic and dynamic model in conscious sedation. This standard model is based on the electroencephalogram (EEG) changes induced by this opioid as a proxy for describing the remifentanil analgesic effect, which might be only valid for high concentrations. Validation of the standard remifentanil model for low concentrations under sedation is needed for safer remifentanil administration.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Pressure pain threshold (PPT) Baseline
Timeframe: Baseline
Pressure pain threshold (PPT) 1.5 minutes
Timeframe: 1.5 minutes
Pressure pain threshold (PPT) 5 minutes
Timeframe: 5 minutes
Pressure pain threshold (PPT) 10 minutes
Timeframe: 10 minutes
Pressure pain threshold (PPT) 15 minutes
Timeframe: 15 minutes
Pressure pain threshold (PPT) 18 minutes
Timeframe: 18 minutes
Pressure pain threshold (PPT) 20 minutes
Timeframe: 20 minutes
Pressure pain threshold (PPT) 25 minutes
Timeframe: 25 minutes
Infusion rate
Timeframe: Continous measurements every 1 second for the whole experiment of 25 minutes
Remifentanil Plasma Concentration (Cp)
Timeframe: Continous measurements every 1 second for the whole experiment of 25 minutes
Remifentanil Effect Concentration (Ce)
Timeframe: Continous measurements every 1 second for the whole experiment of 25 minutes